Document is current
Any future updates will be listed below
-
Authors
Li, Guanjun
Yang, Xiangdi
Huang, Linxuan
Zheng, Yannan
Xu, Liangfu
Zhang, Zhaoyuan
Li, Junyan
Li, Tingting
Zhang, Yutong
Yang, Yongqin
Li, Yifei
Liu, Zhigang
-
Funding
Funding for this research was provided by:
he National Natural Science Foundation of China (Nos. 82403957)
the Dongguan Social Development Science and Technology Program (No. 20231800900382)
the Beijing Xisike Clinical Oncology Research Foundation (Y-Young2022–0225)
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 1 February 2026
First Online: 11 February 2026
Declarations
:
: The use of human tumor specimens in this study was approved by the Ethics Committee of Dongguan People’s Hospital (The Tenth Affiliated Hospital of Southern Medical University) (Approval No. KYKT2022-045). Written informed consent was obtained from all participants.All experiments involving animals were conducted according to the ethical policies and procedures approved by the Animal Welfare and Ethics Committee of the Tenth Affiliated Hospital of Southern Medical University (Dongguan People’s Hospital) (Approval No. IACUC-AWEC-202406501).
: Not applicable.
: The authors declare no competing interests.
